NEWSROOM

NASDAQ

AmpliTech Group Achieves REACH and RoHS Certification For Its 5G ORAN Low Power and Mid Power Radios, Reinforcing Commitment to Sustainability and Compliance

AmpliTech Group Achieves REACH and RoHS Certification For Its 5G ORAN Low Power and Mid Power Radios, Reinforcing Commitment to Sustainability and Compliance

Apr 21, 2025

Meeting the rigorous regulatory standards required by international markets Listen: HAUPPAUGE, N.Y., April 21, 2025 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a leading designer, developer, and manufacturer of advanced signal processing components for satellite, public and private 5G, and other communications networks, including full 5G/6G system design and global distribution of integrated circuit assembly packages and lids, today is proud to announce that its 5G ORAN...

Aemetis India Plant Receives $31 million of Biodiesel Orders from OMCs for Delivery in Next Three Months

Aemetis India Plant Receives $31 million of Biodiesel Orders from OMCs for Delivery in Next Three Months

Apr 21, 2025

Listen: CUPERTINO, Calif., April 21, 2025 - PRISM MediaWire - Aemetis, Inc. (NASDAQ: AMTX), a diversified global renewable natural gas and biofuels company, announced the Company’s subsidiary in India, Universal Biofuels, received multiple orders for an aggregate of $31 million for the delivery during May, June and July of more than 33,000 kiloliters of biodiesel to the three government-owned Oil Marketing Companies (OMCs). Additional OMC orders are expected throughout the year in order to...

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Apr 21, 2025

Independent Cost-Effectiveness Analysis Concludes Nociscan is Effective and Less Costly Compared to Provocative Discography Conclusions Illustrate Nociscan Saves $1,712 per Patient and Improves Surgical Success by 10% Listen: BROOMFIELD, Colo., April 21, 2025 - PRISM MediaWire - Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians...

AmpliTech Group Achieves REACH and RoHS Certification For Its 5G ORAN Low Power and Mid Power Radios, Reinforcing Commitment to Sustainability and Compliance

AmpliTech Group’s 5G Division Secures Company-Record Approx. US$11 Million Purchase Orders As Part Of A New Multi-Year LOI From Tier 1 North American MNO

Apr 16, 2025

HAUPPAUGE, N.Y., April 16, 2025 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a leading designer, developer, and manufacturer of advanced signal processing components for satellite, public and private 5G, and other communications networks, including full 5G/6G system design and global distribution of integrated circuit assembly packages and lids, today announced the receipt of company-record Purchase Orders valued at approximately US$11 million. These orders are part of a...

PRISM MarketView Spotlights Opus Genetics in New Q&A with CEO George Magrath

PRISM MarketView Spotlights Opus Genetics in New Q&A with CEO George Magrath

Apr 15, 2025

Feature Details Company Milestones and 2025 Catalysts Across Gene Therapy and Ophthalmic Programs NEW YORK, April 15, 2025 - PRISM MediaWire - PRISM MarketView today published a Q&A feature with Dr. George Magrath, Chief Executive Officer of Opus Genetics, Inc. (“Opus Genetics” or the “Company”) (Nasdaq: IRD), a clinical-stage gene therapy company developing treatments for inherited retinal diseases (IRDs) and broader ophthalmic conditions. Dr. George Magrath, Chief Executive Officer of...

NextNRG Reports Preliminary March 2025 Revenue Growth of 161% Year-Over-Year and Q1 Revenue Growth of 146%

NextNRG Reports Preliminary March 2025 Revenue Growth of 161% Year-Over-Year and Q1 Revenue Growth of 146%

Apr 10, 2025

Company Reports Third Consecutive Record Month Listen: MIAMI, April 10, 2025 - PRISM MediaWire - NextNRG, Inc. (Nasdaq: NXXT), a pioneer in AI-driven energy innovation—transforming how energy is produced, managed, and delivered through its advanced Utility Operating System, smart microgrid technology, wireless EV charging, and on-demand mobile fuel delivery solutions— today announced preliminary unaudited revenue and volume results for March 2025 and the first quarter of 2025. The company...

Blackboxstocks Inc. Merger Target REalloys Inc. Acquires Rare Earth Magnet Producer PMT Critical Metals

Blackboxstocks Inc. Merger Target REalloys Inc. Acquires Rare Earth Magnet Producer PMT Critical Metals

Apr 9, 2025

Ohio based PMT Critical Metals Inc. Produces Rare Earth Magnet Materials for the US Defense Logistics Agency and the US Department of Energy Strategic Acquisition Strengthens North American Integrated Rare Earth Mine-to-Magnet Supply Chain Dallas, Texas, April 09, 2025 - PRISM MediaWire -Blackboxstocks Inc. (NASDAQ: BLBX), (“Blackbox” or the “Company”), a financial technology provider and social media hybrid announced that its merger target REalloys Inc. (“REalloys”), has acquired 100% of PMT...

Sono-Tek to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub

Sono-Tek to Present at the Planet MicroCap Showcase: VEGAS in partnership with MicroCapClub

Apr 9, 2025

Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025 MILTON, N.Y., April 9, 2025 - PRISM MediaWire - Sono-Tek Corporation (Nasdaq: SOTK), the leading developer and manufacturer of ultrasonic coating systems, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub on Wednesday, April 23, 2025 at 1:30 PM ET. Dr. Christopher L. Coccio, Executive Chairman and Steve Harshbarger, CEO...

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub

Apr 9, 2025

Wednesday, April 23, 2025 & 1x1 Meetings on Thursday, April 24, 2025 Broomfield, CO, April 9, 2025 - PRISM MediaWire -Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, today announced that it will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership with...

Aemetis India Plant Receives $31 million of Biodiesel Orders from OMCs for Delivery in Next Three Months

Aemetis Biogas Monthly RNG Production Increased by 55% in March

Apr 8, 2025

Sales of LCFS credits and D3 RINs completed at the end of Q1 CUPERTINO, Calif., April 08, 2025 - PRISM MediaWire - Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable fuels company focused on low and negative carbon intensity renewable fuels, announced today that its production of renewable natural gas (RNG) increased 55% in March compared to February. RNG production from anaerobic dairy digesters increases during periods of warmer weather due to improved temperatures for...

Lipella Pharmaceuticals Completes Enrollment in Phase 2a Trial of LP-310 for Oral Lichen Planus

Lipella Pharmaceuticals Completes Enrollment in Phase 2a Trial of LP-310 for Oral Lichen Planus

Apr 8, 2025

Topline Results Expected Q2 2025 Listen: PITTSBURGH, April 08, 2025 - PRISM MediaWire - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing innovative therapies for unmet medical needs, today announced the completion of enrollment in its Phase 2a multicenter, dose-ranging trial evaluating LP-310, a liposomal tacrolimus oral rinse for the treatment of oral lichen planus (OLP). The Phase 2a trial has now fully...

AmpliTech Group Achieves REACH and RoHS Certification For Its 5G ORAN Low Power and Mid Power Radios, Reinforcing Commitment to Sustainability and Compliance

AmpliTech Group, Inc. Highlights “Made in the USA” Products Amidst Booming Industry Growth and Global Trade Tensions

Apr 7, 2025

HAUPPAUGE, NY, April 7, 2025 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly a premier designer, developer, and manufacturer of advanced signal processing components and systems, reaffirms its...

NextNRG Reports Preliminary March 2025 Revenue Growth of 161% Year-Over-Year and Q1 Revenue Growth of 146%

NextNRG Extends Fueling Services to Sunbelt Rentals in Texas, Advancing Recurring Revenue Strategy

Apr 4, 2025

NextNRG (NASDAQ: NXXT) extends its commercial partnership with Sunbelt Rentals, expanding fueling operations from Florida to Texas Fueling operations now span six states with 144 active trucks, enabling broader service coverage and supporting growth in key commercial markets February fuel deliveries experienced 166% year-over-year growth MIAMI, April 4, 2025 - PRISM MediaWire - NextNRG, Inc. (NASDAQ: NXXT), a pioneer in AI-driven energy innovation—transforming how energy is produced, managed...

SKYX Announces U.S. Manufacturing Partnership with Prominent Electronic Manufacturer Profab Electronics

SKYX Announces U.S. Manufacturing Partnership with Prominent Electronic Manufacturer Profab Electronics

Apr 3, 2025

Profab Electronics is a High-Quality Manufacturer with Mass Production Capabilities and a 60,000 SQF Manufacturing Facility in Florida Miami, April 3, 2025 - PRISM MediaWire - SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive advanced and smart home platform technology company for homes and buildings, with more than 97 issued and pending patents globally and a portfolio of over 60 lighting and home décor websites, today announces a strategic manufacturing partnership with...

Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference

Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference

Apr 2, 2025

IRVINE, Calif., April 2, 2025 - PRISM MediaWire - Oncocyte Corp. (Nasdaq: OCX), a leading diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief Financial Officer Andrea James will attend the 24th Annual Needham Virtual Healthcare Conference, taking place from April 7-10, 2025. In addition, CEO Josh Riggs will participate in a fireside chat at the conference. During the event, Josh and Andrea will discuss Oncocyte’s innovative diagnostic technologies...

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California

Apr 2, 2025

MICSC are leaders in Los Angeles providing MRI and Diagnostic Imaging services MICSC expands access to Nociscan beyond Beverly Hills now available in Santa Monica Broomfield, CO, April 2, 2025 - PRISM MediaWire - Aclarion, Inc.,(“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today its Nociscan...

BioStem Technologies Announces Extension to File 2024 Annual Report with OTC

BioStem Technologies Announces Extension to File 2024 Annual Report with OTC

Apr 1, 2025

POMPANO BEACH, Fla., April 1, 2025 - PRISM MediaWire - BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company specializing in the development, manufacturing, and commercialization of placental-derived products for advanced wound care, announces it has filed for an extension to submit its annual report for the year ended December 31, 2024 to the OTC The company is currently undergoing a mandatory Securities Exchange Commission (SEC) review process related to its Form 10 registration...

AmpliTech Group Achieves REACH and RoHS Certification For Its 5G ORAN Low Power and Mid Power Radios, Reinforcing Commitment to Sustainability and Compliance

AmpliTech Reports FY 2024 Financial Results

Apr 1, 2025

Working Capital of $27 Million; Over $19 Million in Cash; Zero Debt 5G Division’s ORAN Products Positioned for Strong FY 2025 Performance HAUPPAUGE, N.Y., April 01, 2025 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG), a leading designer, developer, and manufacturer of advanced signal-processing components for satellite, 5G, and other communication networks, including complete 5G/6G system design, and a global distributor of packaging and lid solutions for integrated circuit assembly,...

Lipella Pharmaceuticals Completes Enrollment in Phase 2a Trial of LP-310 for Oral Lichen Planus

Lipella Pharmaceuticals Co-Founder Michael Chancellor Featured on the Pharmaverse Podcast

Mar 31, 2025

Episode titled "From Medicine to Biotech Innovation" now available PITTSBURGH, March 31, 2025 - PRISM MediaWire - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us,” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet needs, today announced that Co-Founder and Chief Medical Officer Dr. Michael Chancellor is featured in the latest episode of The Pharmaverse Podcast, hosted by pharmaceutical industry executive recruiter...

AmpliTech Group Achieves REACH and RoHS Certification For Its 5G ORAN Low Power and Mid Power Radios, Reinforcing Commitment to Sustainability and Compliance

AmpliTech Group Secures Major Milestone: Receives Initial Purchase Order from Leading 5G ORAN Player Marking Beginning Of US$78M Announced LOI

Mar 31, 2025

Hauppauge, NY, March 31, 2025 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, proudly announces the receipt of an initial purchase order valued at nearly $1M, as part of a groundbreaking...

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives

Mar 31, 2025

Over $20M raised in Q1 with nearly $15M cash on hand No debt, no preferred equity, and no warrants with strike prices near the current market Nasdaq compliant: fully meets bid price and shareholder equity requirements Pivotal CLARITY trial fully funded with initial interim results expected in Q2 2026 Broomfield, CO, March 31, 2025 - PRISM MediaWire - Aclarion, Inc.,(“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary...

NextNRG Reports Preliminary March 2025 Revenue Growth of 161% Year-Over-Year and Q1 Revenue Growth of 146%

NextNRG, Inc. Reports February 2025 Revenue Exceeding January’s Record, Driving Continued Momentum in Smart Fueling Operations

Mar 28, 2025

February Revenue up 139% Year-over-Year from $2.1m to $5.9m With Second Consecutive Month of Record Performance, February Revenue Surpasses January Despite Fewer Operating Days MIAMI, Florida, March 28, 2025 - PRISM MediaWire - NextNRG, Inc. (“NextNRG” or the “Company”) (Nasdaq: NXXT), a pioneer in AI-driven energy innovation—transforming how energy is produced, managed, and delivered through its advanced Utility Operating System, smart microgrid technology, wireless EV charging, and on-demand...

NextNRG Reports Preliminary March 2025 Revenue Growth of 161% Year-Over-Year and Q1 Revenue Growth of 146%

NextNRG Reports Strong Fourth Quarter and Full Year 2024 Financial Results

Mar 27, 2025

Stronger Revenue, Improved Margins, and Expanded Volumes FY 2024 Revenue Increased 20% to $27.8 Mllion from $23.2 Million in 2023 FY 2024 Gross Profit Grew 64% to $2.3 Million, Up from $1.4 Million in 2023 Q4 2024 Revenue Increased 21% to $6.9 Million from $5.7 Million in Q4 2023 Q4 2024 Gross Profit Grew 97% to $652 Thousand, Up from $330 Thousand in Q4 2023 Conference Call Scheduled March 31st at 4:30 PM ET MIAMI, FL, March 27, 2025 - PRISM MediaWire - NextNRG, Inc. (NASDAQ: NXXT), a pioneer...

Auddia Announces Reverse Stock Split

Auddia Announces Reverse Stock Split

Mar 27, 2025

BOULDER, CO, March 27, 2025 - PRISM MediaWire - Auddia Inc., (“Auddia” or the “Company”) (NASDAQ: AUUD, AUUDW), an AI first technology company that has built a proprietary AI platform for audio identification and classification to reinvent how consumers engage with audio, today announced that effective before market open on Monday March 31, 2025, it will complete a 1-for-17 reverse stock split of its common stock. On December 30, 2024, the Company’s stockholders approved an amendment to the...

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Aclarion Announces Reverse Stock Split

Mar 26, 2025

BROOMFIELD, Colo., March 26, 2025 - PRISM MediaWire - Aclarion, Inc., (“Aclarion” or the “Company”) (NASDAQ: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence algorithms to help physicians identify the location of chronic low back pain, today announced that effective before market open on Friday March 28, 2025, it will complete a 1-for-27 reverse stock split of its common stock. On September 23, 2024, the Company’s stockholders...

Oncocyte to Participate in 24th Annual Needham Virtual Healthcare Conference

Oncocyte Reports Successful 2024; Sets Stage for 2025 Catalysts

Mar 24, 2025

Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 million GraftAssure RUO assay launched July 2024 Signed strategic partner and investor, Bio-Rad Laboratories Fully funded clinical kitted product development with $50+ million in equity raises Advanced science in transplant; achieved Medicare claims expansion IRVINE, Calif., March 24, 2025 - PRISM MediaWire - Oncocyte Corp. (Nasdaq: OCX), a diagnostics technology company, today published the following letter to...

SKYX Announces U.S. Manufacturing Partnership with Prominent Electronic Manufacturer Profab Electronics

SKYX Reports 48% Revenue Growth in 2024 — From $58.8 Million in 2023 to $86.3 Million in 2024

Mar 24, 2025

Sales of SKYX’s Advanced and Smart Home Related Products Surge Over 1,000%; SKYX Expects its products to be in 20,000 Units/Homes by Q1 2025 and an Additional Tens of Thousands of Units/Homes in 2025 Company Expects Significant Projects and Orders and to Become Cash Flow Positive in Second Half of 2025 SKYX Achieves Revenue Growth in Four Consecutive Quarters for 2024 Q1: $19M | Q2: $21M | Q3: $22.2M | Q4: $23.7M Record Sales SKYX’s Safety Code Standardization Team Anticipates Support from...

AmpliTech Group Achieves REACH and RoHS Certification For Its 5G ORAN Low Power and Mid Power Radios, Reinforcing Commitment to Sustainability and Compliance

AmpliTech Group’s 5G Division Enters Into An LOI For US$78 Million In Purchase Orders For AmpliTech’s 5G ORAN Radios

Mar 24, 2025

Key Highlights: Major $78 Million LOI for 5G ORAN Radios: AmpliTech Group, Inc. (Nasdaq: AMPG) has signed a non-binding Letter of Intent (LOI) for the purchase of $78 million worth of 5G ORAN radios. The order, subject to definitive agreements, is expected to commence delivery in FY2025, with increasing volumes through 2027. Expanding Leadership in 5G and Communication Solutions: Leveraging its advanced design and manufacturing capabilities, AmpliTech continues to strengthen its market...

PRISM MarketView Spotlights NextNRG’s Record Growth Amid Surging Energy Demand and AI-Driven Infrastructure Investments

PRISM MarketView Spotlights NextNRG’s Record Growth Amid Surging Energy Demand and AI-Driven Infrastructure Investments

Mar 24, 2025

CEO Michael Farkas Discusses the Company’s Breakout Expansion, Mobile Fueling Success, and Vision for AI/ML-Powered, Decentralized Energy NEW YORK, March 24, 2025 – PRISM MediaWire - PRISM MarketView has released an exclusive interview with Michael Farkas, CEO of NextNRG Inc. (NASDAQ: NXXT), highlighting the company’s record-breaking growth and its role at the forefront of the AI-powered energy revolution. As global demand for decentralized, sustainable, and intelligent energy solutions...

SKYX Announces U.S. Manufacturing Partnership with Prominent Electronic Manufacturer Profab Electronics

SKYX Announces Corporate Update Call

Mar 20, 2025

Company to Provide Corporate Updates Including New Developments, Fourth Quarter 2024 and 2024 Full Year Overview and Financial Results; Conference Call to be Held on Monday March 24, 2025, at 4:30 PM Eastern Time Miami, March 20, 2025 - PRISM MediaWire - SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive advanced and smart home platform technology company for homes and buildings, with more than 97 issued and pending patents globally and a portfolio of over 60 lighting and...